• Info
  • Home
  • About
  • Editorial Board
  • Archive
  • Research Topics
  • View Some Authors
  • Review Guidelines
  • Subscribe to Alerts
  • Search
  • Article Type

    Publication Date

  • Author Info
  • Why Submit?
  • Fees
  • Article Types
  • Author Guidelines
  • Submission Checklist
  • Contact Editorial Office
  • Submit Manuscript
Start date should be earlier than end date. OK Please enter the date in dd/mm/yyyy format or use the calendar icon to the left of the date field.

Research Topic

Share 0
Like 0

Hematopoietic stem/progenitor cells in inflammation and allergy

Topic Editors:

Zoulfia Allakhverdi, University of Montreal, Canada
Roma Sehmi, McMaster University, Canada

Submission Closed.

Hematopoietic stem/progenitor cells (HSPCs) reside within the bone marrow (BM) where they give rise to all hematopoietic populations. In steady state conditions, hematopoietic progenitors constantly egress from the BM into the blood, and circulate through the peripheral tissues where upon encounter with inflammatory stimuli they may differentiate into tissue dwelling and effector cells. In the allergic diseases, the number of BM and circulating progenitor cells increases during exacerbation of asthma or after allergen challenge and they accumulate in the bronchial mucosa and the sputum of allergic asthmatics. Circulating CD34+ progenitor cells migrating to the site of allergic inflammation differentiate into mast cells, eosinophils and basophils, the typical effector cells of allergic responses, and may also contribute directly or indirectly to the differentiation of tissue dwelling cells involved in the remodelling of the airway structure, such as endothelial cells and myofibroblasts. However, recent data indicated that shortly after their recruitment to the site of inflammation/injury, HSPCs rapidly release very high levels of Th2 cytokines/chemokines in response to thymic stromal lymphopoietin (TSLP) and IL-33, even before their differentiation into effector cells. This novel concept of their dual function as precursors and potent Th2 cytokine producers has important clinical implications in various inflammatory conditions including allergic diseases. Th2 profile of molecules released by the activated progenitors will also permit to appreciate their protective involvement in cardiovascular diseases, ischemia, and wound healing. We still do not fully appreciate the role of progenitor cells in these healing/inflammatory processes. Understanding these early innate Th2 type immune responses and inflammatory mediators that are important for the initiation of these responses will be the key to designing novel therapies.

Share 0
Like 0

About Frontiers Research Topics


Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

© 2007 - 2014 Frontiers Media S.A. All Rights Reserved